Virginia Commonwealth University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Virginia Commonwealth University sits in the top decile of US sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count).
Virginia Commonwealth University: 558 sponsored US clinical trials, 77 recruiting.
Virginia Commonwealth University sponsors 558 registered US clinical trials on ClinicalTrials.gov, 77 of them currently recruiting, and 380 completed. 35 of these trials are in Phase 3-4 (later-stage) and 145 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 8 trials.
Top-decile sponsor footprint
Virginia Commonwealth University ranks in the top decile of sponsors by registered trial count (#63 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
380 of 462 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
558 total, page 9 of 12
Recruiting and Retaining Young Adults in Behavioral Weight Loss Treatment
NCT01889082
Motivational Interviewing in NOURISH for Parents of Overweight Children
NCT01912989
Knee Arthroplasty Pain Coping Skills Training (KASTPain): A Randomized Trial
NCT01620983
Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
NCT02197845
Motivational Interviewing for Weight Loss With Young Adults
NCT01899625
Motivational Interviewing Integrated With Social Network Counseling for Teens
NCT01922947
A Trial of Neurocognitive and Supportive Therapy Interventions for Individuals With Parkinson's Disease
NCT01646333
Feasibility Study of SPEEDI
NCT01889108
The Effect of Humidification on Mucus Rheology
NCT01661374
Safety and Efficacy of Doxycycline in Patients With Non-Ischemic Cardiomyopathy
NCT01935622
International Plastic Bronchitis Registry
NCT01663948
Colorectal Cancer Screening With Improved Shared Decision Making
NCT01519999
Behavioral Incentives to Increase Exercise in Cocaine Dependent Women
NCT01283191
Computer-based Cognitive Training for Individuals With Parkinson's Disease
NCT02225314
Soft Tissue Detection on MRI, Cone Beam CT and Fan Beam CT and Integration of Functional MRI
NCT01859338
Examining a Common Complaint of Women Who Receive Chemotherapy for Breast Cancer- Cognitive Difficulty
NCT01553097
Randomized Trial of the Effectiveness of Topical "ABH Gel" vs. Placebo in Cancer Patients With Nausea
NCT01556932
An Observational Study to Evaluate The Relationship of Nasal Mucus Properties and Symptoms
NCT01553110
Pilot Feasibility Study of the Safety and Efficacy of Anakinra in Heart Failure With Preserved Ejection Fraction
NCT01542502
Evaluation of a Computer-Delivered 5 A's Intervention for Smoking
NCT01383278
Yoga in Improving Quality of Life in Patients With Non-small Cell Lung Cancer Undergoing Treatment
NCT02895503
Blood Vessel Function in Adolescents and Women With Polycystic Ovary Syndrome
NCT01615562
Oral Contraceptives, Insulin Resistance and Cardiovascular Risk Profile in Pre-Menopausal Women
NCT01475513
Computerized Screening, Brief Intervention, and Referral to Treatment in Primary Care
NCT01003834
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Pulmonary Hypertension
NCT01479010
Recording for Potential AF Drivers and Patient Specific Atrial Anatomy & Atrial Electrogram Maps
NCT01581437
Pemetrexed Disodium and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors
NCT01450384
Study of a Structured Parent Intervention on Adolescent Weight Loss Modification Program.
NCT02086851
Randomized RT +/- Lapatinib for Advanced Solid Tumor Cancer Patients Receiving Radiation Therapy for Metastatic Disease
NCT01427322
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
NCT01375699
Assessment of Inspiratory Profiles Through Airflow Resistances Designed to Mimic Inhalers
NCT01410877
Expressive Writing for Individuals With Parkinson's Disease and Their Caregivers
NCT02217735
An Integrative Intervention for Loss of Control Eating Among Adolescent Girls
NCT01395355
Hydroxychloroquine in Treating Patients With Solid Tumors Undergoing Radiation Therapy for Bone Metastases
NCT01417403
Safety Study of R(+)Pramipexole to Treat Early Alzheimer's Disease
NCT01388478
Phase I Study of IMRT and Molecular-Image Guided Adaptive Radiation Therapy for Advanced HNSCC
NCT01283178
Registry for Patients Undergoing Pulmonary Procedures
NCT01397292
Reduce Cardiovascular Risk in Women Through Tai Chi Intervention
NCT01467544
The Effect of Oral Guaifenesin on Pediatric Chronic Rhinitis: A Pilot Study
NCT01364467
NOURISH+: Nourishing Our Understanding of Role Modeling to Improve Support and Health
NCT01361243
Hormone Therapy Or Chemotherapy Before Surgery Based on Gene Expression Analysis in Treating Patients With Breast Cancer
NCT01293032
Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures
NCT01639534
Brief Computerized Feedback for Smokers in Recovery
NCT01325727
Pilot Study of the Safety and Efficacy of Anakinra (Recombinant Human Interleukin-1 Receptor Antagonist) in Heart Failure
NCT01300650
Prediction of Severity of Liver Disease by a 13C Octanoate Breath Test (OBT)
NCT01244503
Epigenetics and Psychoneurologic Symptoms in Women With Breast Cancer
NCT01411943
Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol Gel in Healthy Volunteers
NCT01204255
Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer
NCT01196442
Flail Chest - Rib Fixation Study
NCT01147471
Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer
NCT01075113
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 65 |
| Phase 3 | 13 |
| Phase 4 | 22 |
Therapeutic Areas
What is open in the Virginia Commonwealth University pipeline
77 recruiting of 558 indexed (14% open); 380 completed (68%).
Phase mix: 35 late (III/IV) vs 145 early (I/II) (early-phase heavy).
Top condition: Obesity (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Virginia Commonwealth University: open-pipeline peers nationwide
Peers matched on 558 registered trials and 14% open enrollment, not the therapeutic-area sidebar.
Virginia Commonwealth University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 558 trials (± recruiting share)
- Amgen · 558 trials · 10% recruiting
- Merck Sharp & Dohme · 558 trials · 22% recruiting
- University of Maryland, Baltimore · 560 trials · 18% recruiting
- Ohio State University · 552 trials · 21% recruiting
Sponsors near 14% open enrollment (± trial volume)
- Lindenwood University · 14% recruiting · 29 trials
- BeiGene · 14% recruiting · 65 trials
- Reproductive Medicine Associates of New Jersey · 14% recruiting · 51 trials
- University of Cincinnati · 14% recruiting · 245 trials
Related
What to do with this Virginia Commonwealth University page
558 registered trials is a research-attention snapshot, not an endorsement of Virginia Commonwealth University or any single study.
- 77 of Virginia Commonwealth University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Virginia Commonwealth University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Virginia Commonwealth University pipeline card: 558 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.